APRICollaborationprnewswire

Apriori Bio Announces Collaboration with the Francis Crick Institute

Sentiment:Positive (70)

Summary

Apriori to leverage foundational insights from the Crick's Legacy Study to further validate Octavia™ platform's ability to predict viral evolution and vaccine performance CAMBRIDGE, Mass., Aug. 12, 2025 /PRNewswire/ -- Apriori Bio, a biotechnology company focused on developing...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 12, 2025 by prnewswire